Last $1.33 USD
Change Today -0.02 / -1.48%
Volume 12.2M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - EXELIXIS INC (EXEL)

Exelixis, Inc. to Report Q3, 2014 on Nov 04, 2014
CapIQ 11/04/2014 10:00 PM ET
Exelixis, Inc. to Report Q2, 2014 on Jul 31, 2014
CapIQ 11/04/2014 10:00 PM ET
Exelixis, Inc. to Report Q1, 2014 on May 01, 2014
CapIQ 11/04/2014 10:00 PM ET

2013 revenues at Exelixis, Inc. totaled $31.3M USD, while annual losses equaled $1.32 per share.

Quarterly Earnings & Estimates - EXELIXIS INC (EXEL)

Actuals vs. Estimates for EXELIXIS INC EXEL

Exelixis, Inc.'s Quarterly Earnings

Exelixis, Inc. reported 2nd quarter 2014 losses of $0.37 per share on 08/2/2014.

Annual Earnings & Estimates - EXELIXIS INC (EXEL)

Actuals vs. Estimates for EXELIXIS INC EXEL

Exelixis, Inc.'s Annual Earnings

Exelixis, Inc. reported annual 2013 losses of $1.32 per share on 02/22/2014.

Quarterly Revenues - EXELIXIS INC (EXEL)

Actuals vs. Estimates for EXELIXIS INC EXEL

Exelixis, Inc.'s Quarterly Revenues

Exelixis, Inc. had 2nd quarter 2014 revenues of $6.6M USD. This bettered the $6.0M USD consensus of the 6 analysts covering the company. This was -44.7% below the prior year's 2nd quarter results.

Annual Revenues - EXELIXIS INC (EXEL)

Actuals vs. Estimates for EXELIXIS INC EXEL

Exelixis, Inc.'s Annual Revenues

Exelixis, Inc. had revenues for the full year 2013 of $31.3M USD. This was -34.0% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $1.33 USD -0.02

EXEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AVEO Pharmaceuticals Inc $0.85 USD +0.04
CrystalGenomics Inc 11,500 KRW +250.00
Curis Inc $1.17 USD +0.02
Cytokinetics Inc $4.89 USD 0.00
Rigel Pharmaceuticals Inc $2.44 USD +0.09
View Industry Companies
 

Industry Analysis

EXEL

Industry Average

Valuation EXEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.